Teacher Retirement System of Texas Sells 66,881 Shares of Tempus AI, Inc. $TEM

Teacher Retirement System of Texas lessened its holdings in Tempus AI, Inc. (NASDAQ:TEM) by 85.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,480 shares of the company’s stock after selling 66,881 shares during the period. Teacher Retirement System of Texas’ holdings in Tempus AI were worth $729,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Bank of New York Mellon Corp lifted its position in Tempus AI by 27.5% during the first quarter. Bank of New York Mellon Corp now owns 60,965 shares of the company’s stock valued at $2,941,000 after purchasing an additional 13,142 shares during the last quarter. Envestnet Asset Management Inc. raised its position in shares of Tempus AI by 37.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 60,447 shares of the company’s stock valued at $2,916,000 after buying an additional 16,328 shares in the last quarter. Brown Advisory Inc. purchased a new stake in shares of Tempus AI during the 1st quarter valued at about $209,000. Axxcess Wealth Management LLC lifted its holdings in shares of Tempus AI by 17.5% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,709 shares of the company’s stock valued at $372,000 after acquiring an additional 1,148 shares during the last quarter. Finally, Diversify Wealth Management LLC purchased a new position in Tempus AI in the first quarter worth about $2,593,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Stock Down 0.7%

Shares of NASDAQ:TEM opened at $71.56 on Friday. The firm has a market capitalization of $12.43 billion, a PE ratio of -60.13 and a beta of 4.86. The business has a 50 day simple moving average of $85.91 and a two-hundred day simple moving average of $70.82. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $104.32. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 1.43.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The firm had revenue of $334.21 million during the quarter, compared to analyst estimates of $328.89 million. During the same period last year, the company earned ($0.46) EPS. Tempus AI’s quarterly revenue was up 84.7% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. On average, equities analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Buying and Selling at Tempus AI

In other news, CFO James William Rogers sold 7,528 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the transaction, the chief financial officer directly owned 138,473 shares in the company, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Ryan M. Bartolucci sold 1,904 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $142,133.60. Following the completion of the transaction, the chief accounting officer directly owned 45,895 shares in the company, valued at $3,426,061.75. This represents a 3.98% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 1,105,282 shares of company stock valued at $87,726,381. 26.27% of the stock is owned by company insiders.

Analysts Set New Price Targets

TEM has been the topic of several analyst reports. BTIG Research reissued a “buy” rating and set a $96.00 price objective on shares of Tempus AI in a research note on Wednesday. Cowen cut Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Canaccord Genuity Group decreased their price target on Tempus AI from $110.00 to $95.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, HC Wainwright dropped their price objective on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a research note on Friday. Seven analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $79.85.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.